Validation of the French version of the MacNew heart disease health-related quality of life questionnaire  by Pavy, Bruno et al.
Archives of Cardiovascular Disease (2015) 108, 107—117
Available  online  at
ScienceDirect
www.sciencedirect.com
CLINICAL RESEARCH
Validation  of  the  French  version  of  the
MacNew  heart  disease  health-related
quality  of  life  questionnaire
Validation  de  la  version  franc¸aise  du  questionnaire  de  qualité  de
vie  en  cardiologie  MacNew
Bruno  Pavya,∗,  Marie-Christine  Ilioub,  Stefan  Höferc,
Bénédicte  Vergès-Patoisd,  Sonia  Coronee,
Patrick  Aeberhardf,  Daniel  Curnierg,h,
Jacques  Henry i,  Anne  Ponchon-Weess i,  Neil  Oldridgej
a Cardiovascular  rehabilitation  department,  Loire-Vendée-Océan  hospital,  boulevard  des
Régents, 44270  Machecoul,  France
b Cardiac  rehabilitation  department,  Corentin-Celton  hospital,  AP—HP,  Issy-Les-Moulineaux,
France
c Department  of  medical  psychology,  Innsbruck  medical  university,  Innsbruck,  Austria
d Cardiac  rehabilitation  unit,  clinique  SSR  les  Rosiers,  Dijon,  France
e Cardiac  rehabilitation  department,  Bligny,  France
f Centre  cardiologique  du  Nord,  Saint-Denis,  France
g Research  center,  Sainte-Justine  hospital,  Montreal,  QC,  Canada
h Cardiovascular  and  pulmonary  rehabilitation  centre,  Saint-Orens,  France
i RECOR  Orangerie  centre,  Strasbourg,  France
j College  of  Health  Sciences,  University  of  Wisconsin-Milwaukee,  Milwaukee,  Wisconsin,  USA
Received 19  May  2014;  received  in  revised  form  16  September  2014;  accepted  18  September
2014
Available  online  12  November  2014
Abbreviations: HADS, Hospital Anxiety and Depression Scale; HQRL, health-related quality of life; IHD, ischaemic heart disease;
MCS, mental component summary; MI, myocardial infarction; MID, minimal important difference; NYHA, New York Heart Association; PCI,
percutaneous coronary intervention; PCS, physical component summary; SF-36, Short Form-36 Health Survey.
∗ Corresponding author.
E-mail address: pavy.bruno@wanadoo.fr (B. Pavy).
http://dx.doi.org/10.1016/j.acvd.2014.09.006
1875-2136/© 2014 Elsevier Masson SAS. All rights reserved.
108  B.  Pavy  et  al.
KEYWORDS
Quality  of  life;
MacNew
questionnaire;
French  version;
Ischaemic  heart
disease
Summary
Background.  —  Assessment  of  health-related  quality  of  life  is  widely  recommended  by  European
health agencies  in  relevant  research  studies  as  well  as  in  clinical  care.
Aims.  —  To  validate  the  French  version  of  the  MacNew  heart  disease  health-related  quality  of
life questionnaire.
Methods.  —  As  part  of  the  International  HeartQoL  Project,  323  French-speaking  patients  with
ischaemic  heart  disease  (angina,  n  =  76;  myocardial  infarction  [MI],  n  =  155;  heart  failure,  n  =  91;
mean age  58.6  ±  11.3  years)  were  recruited  at  seven  cardiac  rehabilitation  centres.  All  patients
completed  the  French  versions  of  the  MacNew  questionnaire,  the  Short  Form-36  Health  Survey
(SF-36) and  the  Hospital  Anxiety  and  Depression  Scale,  to  evaluate  the  psychometric  properties
of the  French  version  of  the  MacNew  instrument.
Results.  —  The  mean  MacNew  global  scale  scores  were  4.6  ±  0.8,  5.0  ±  1.0  and  4.8  ±  0.9  in
patients with  angina,  MI  and  heart  failure,  respectively  (P  <  0.05,  MI  versus  angina).  We  observed
minimal missing  items  and  ceiling  effects  and  no  ﬂoor  effects.  Factor  analysis  conﬁrmed  a  three
factorial structure  explaining  55.9%  of  the  observed  variance.  Internal  consistency  reliability
(Cronbach’s  )  ranged  from  0.86  to  0.94  and  test-retest  reliability  ranged  from  0.68  to  0.73  Con-
vergent validity  was  conﬁrmed  in  the  total  group  and  each  diagnosis,  although  the  correlations
between the  MacNew  physical  subscale  and  the  SF-36  mental  component  summary  were  higher
than expected.  Discriminative  validity  was  partially  conﬁrmed  with  the  SF-36  health  transition
item and  fully  conﬁrmed  with  anxiety  and  depression  as  predictor  variables.
Conclusion.  —  The  French  version  of  MacNew  questionnaire  is  recommended  for  assessing
health-related  quality  of  life  in  French-speaking  patients  with  ischaemic  heart  disease.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  L’utilisation  d’un  questionnaire  de  qualité  de  vie  est  largement  recommandée  par
les agences  de  santé  européennes  tant  en  recherche  que  dans  la  pratique  clinique.
Objectifs.  —  Le  but  de  cette  étude  était  de  valider  la  version  franc¸aise  du  questionnaire  de
MacNew en  cardiologie.
Méthodes.  —  Dans  le  cadre  du  projet  international  HeartQoL,  323  patients  francophones  coro-
nariens (angor,  n  =  76  ;  post-infarctus,  n  =  155  ;  insufﬁsants  cardiaques,  n  =  91)  d’une  moyenne
d’âge de  58,6  ±  11,3  ans,  ont  été  inclus  dans  7  centres  de  réadaptation  cardiaque.  Tous  ont
complété les  versions  franc¸aises  du  MacNew,  du  Short  Form-36  (SF-36)  et  de  l’échelle  Hospital
Anxiety Depression  (HAD)  dans  le  but  d’évaluer  les  propriétés  psychométriques  du  questionnaire
MacNew franc¸ais.
Résultats.  — Le  score  global  du  MacNew  était  de  4,6  ±  0,8,  5,0  ±  1,0  et  4,8  ±  0,9,  respective-
ment dans  l’angor,  en  post-infarctus  et  dans  l’insufﬁsance  cardiaque  (p  <  0,05  entre  infarctus  et
angor). Nous  avons  observé  peu  de  données  manquantes,  d’effet  plancher  et  l’absence  d’effet
plafond. L’analyse  factorielle  a  abouti  à  une  structure  en  trois  composantes  qui  expliquent
55,9 %  de  la  variance  observée.  Les  coefﬁcients  de  consistance  interne  (Cronbach’s  alpha)
étaient compris  entre  0,86  et  0,94  et  du  test-retest  entre  0,68  et  0,73.  La  validité  de  conver-
gence était  obtenue  dans  la  population  totale  et  dans  chaque  groupe  clinique  avec  une
corrélation  plus  élevée  qu’attendue  entre  la  composante  physique  du  MacNew  et  le  SF-36  men-
tal component  summary.  La  validité  discriminante  était  conﬁrmée,  partiellement  avec  les  items
du SF3-6  transition,  et  totalement  avec  l’échelle  HAD.
Conclusion.  —  La  version  franc¸aise  du  questionnaire  MacNew  peut  être  recommandée  pour
analyser la  qualité  de  vie  des  patients  coronariens.
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ntroduction
raditionally,  outcomes  of  existing  and  new  therapies  have
een  focused  on  mortality  and  morbidity.  However,  in
ddition  to  mortality  and  morbidity,  agencies  such  as  the
uropean  Medicines  Agency  [1]  and  the  US  Food  and  Drug
dministration  [2]  recommend  the  use  of  patient-centred
A
a
ts  droits  réservés.
utcome  measures,  such  as  health-related  quality  of  life
HRQL),  in  relevant  research  studies  as  well  as  in  clinical
are.  This  recommendation  is  supported  by  the  National
eart,  Lung  and  Blood  Institute  [3]  and  the  American  Heart
ssociation  [4]  in  patients  with  cardiovascular  disease,  and
 recent  report  by  the  French  Health  Authority  also  supports
he  use  of  patient-centred  outcome  measures,  especially  in
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nValidation  of  MacNew  heart  disease  HRQL  questionnaire  
patients  with  myocardial  infarction  (MI)  [5].  The  two  basic
formats  for  HRQL  questionnaires  —  generic  and  disease-
speciﬁc  instruments  —  are  designed  for  different  purposes.
Generic  HRQL  questionnaires  are  designed  to  assess  a  wide
range  of  health  states,  while  speciﬁc  HRQL  questionnaires,
with  a  focus  on  disease-relevant  issues,  are  appropriate  out-
come  measures  in  both  therapeutic  intervention  trials  and
routine  clinical  care  [6,7].  However,  speciﬁc  HRQL  question-
naires  should  be  used  only  in  patients  with  the  diagnosis  for
which  the  instrument  is  validated  and  not  with  an  ‘off-label
diagnosis’.
Marked  health  status  deﬁcits,  including  poor  HRQL,  are
frequently  seen  in  patients  with  ischaemic  heart  disease
(IHD)  [3].  Treatments  such  as  medications,  interventions  and
rehabilitation  in  patients  with  angina,  MI  and  heart  fail-
ure  have  common  therapeutic  goals  that  include  symptom
management  and  improvement  of  HRQL.  Across-diagnosis
HRQL  treatment  outcome  comparisons  within  a  disease  are
not  possible  with  a  diagnosis-speciﬁc  HRQL  questionnaire
and  require  the  use  of  either  a  generic  HRQL  question-
naire  or,  alternatively,  a  core  HRQL  questionnaire  validated
in  each  diagnosis.  Core  HRQL  questionnaires  have  been
standard  practice  for  20  years  or  more  in  oncology  [8],  where
across-diagnosis  treatment  comparisons  are  possible,  allow-
ing  an  understanding  of  the  range  of  HRQL  across  diagnoses.
Comparisons  across  diagnoses  such  as  angina,  MI  and
heart  failure  should  not  be  made  with  an  IHD  diagnosis-
speciﬁc  HRQL  tool.  For  example,  the  Seattle  Angina
Questionnaire  item  stem  refers  speciﬁcally  to  ‘chest
pain,  chest  tightness  or  angina’  [9],  while  the  Min-
nesota  Living  with  Heart  Failure  questionnaire  [10]  item
stem  refers  speciﬁcally  to  ‘your  heart  failure’,  precluding
across-diagnosis  comparisons.  On  the  other  hand,  the  self-
administered  MacNew  Heart  Disease  HRQL  questionnaire
uses  an  item  stem  that  refers  to  ‘your  heart  problem’  [11],
allowing  across-diagnosis  comparisons.  The  MacNew  ques-
tionnaire,  a  modiﬁcation  of  the  interviewer-administered
Quality  of  Life  after  Myocardial  Infarction  questionnaire
[12,13],  was  originally  developed  and  validated  in  724
English-speaking  patients  with  MI  [11,14].  There  are  now  38
language  versions  of  the  MacNew  questionnaire,  with  vali-
dation  studies  in  patients  with  MI  (n  >  4000)  in  13  languages,
in  patients  with  angina  (n  >  1800)  in  12  languages  and  in
patients  with  heart  failure  (n  >  550)  in  11  languages  [15].
Reliability,  validity,  responsiveness  and  interpretability
are  important  psychometric  properties  of  patient-reported
outcome  measures  [16,17].  As  the  MacNew  questionnaire
has  not  been  validated  in  French-speaking  patients  with
angina,  MI  or  heart  failure,  the  primary  objectives  of  this
study  are  to  report  the  reliability  and  validity  of  the  French
version  of  the  MacNew  questionnaire  in  patients  with  IHD
(regardless  of  the  speciﬁc  diagnosis),  with  angina,  with  MI
and  with  heart  failure.
Methods
PatientsFrench-speaking  patients  with  IHD  and  a  diagnosis  of
angina,  MI  or  heart  failure  were  recruited  at  seven  centres
(Strasbourg,  Bligny  Essonne,  Dijon,  Machecoul,  Saint-Denis,
H
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aint-Orens  and  Les  Moulineaux)  as  part  of  the  interna-
ional  HeartQoL  Project  [18]. The  respective  Institutional
eview  Boards  approved  the  project  and  informed  consent
as  obtained  from  all  subjects.
A  convenience  sample  of  patients  aged  ≥  18  years,  with-
ut  a  documented  psychiatric  disorder  or  active  substance
buse,  who  the  referring  physician  considered  able  to  com-
lete  the  self-administered  battery  of  HRQL  instruments,
ere  eligible  if  they  were  being  treated  for:  angina  (Cana-
ian  Cardiovascular  Society  class  II,  III  or  IV)  with  an
bjective  measure  of  IHD  (e.g.  previous  MI,  exercise  test-
ng,  echocardiogram,  nuclear  imaging  or  angiography);  or
I  diagnosed  at  least  4  weeks  and  <  6  months  previously;  or
schaemic  heart  failure  (New  York  Heart  Association  [NYHA]
lass  II,  III  or  IV),  with  evidence  of  left  ventricular  dysfunc-
ion  (ejection  fraction  ≤  40%  by  invasive  or  non-invasive
esting)  and  an  objective  measure  of  IHD  (e.g.  previous
I,  exercise  testing,  echocardiogram,  nuclear  imaging  or
ngiography).
atient-centred outcome assessment
he  referring  physician  provided  routine  clinical  and  diag-
ostic  data  and  all  patients  completed  a  self-report
ociodemographic  and  clinical  questionnaire.  The  Short
orm-36  Health  Survey  (SF-36),  the  Hospital  Anxiety  and
epression  Scale  (HADS)  and  the  MacNew  questionnaire
ere  administered  at  baseline  to  all  patients  and  2  weeks
ater  to  approximately  20%  of  the  patients  for  test-retest
alidation.
hort  Form-36
he  SF-36  is  a  validated  generic  health  survey  consisting
f  36  items,  with  eight  subscales  summarized  in  a  physical
omponent  summary  (PCS)  and  a  mental  component  sum-
ary  (MCS),  and  has  been  used  extensively  internationally
n  clinical  trials  [19].
ospital  Anxiety  and  Depression  Scale
he  HADS  is  a validated  psychological  screening  instrument
esigned  to  detect  symptoms  of  anxiety  and  depression;  it
as  been  used  extensively  internationally  in  clinical  trials,
ith  scores  ≥  8  used  to  classify  patients  with  symptoms  of
epression  or  anxiety  [20].
acNew  questionnaire
he  development  of  the  MacNew  instrument  has  been
escribed  previously  [21];  it  is  designed  to  assess  a  patient’s
eelings  about  how  IHD  affects  daily  functioning,  and  con-
ains  27  items,  with  a  global  HRQL  scale  and  physical
imitation,  emotional  and  social  function  subscales  [11,14].
he  MacNew  items  and  scales  are  scored  from  1  (low
RQL)  to  7  (high  HRQL)  and  the  minimal  important  dif-
erence  (MID)  on  each  MacNew  scale  is  0.50  points  [22].
sing  forward-backward  translation,  the  MacNew  question-
aire  was  translated  into  French  as  part  of  the  international
eartQoL  Project  [18].  There  is  a licence  fee  for  researchers
nd  clinics  who  wish  to  use  the  French  version  of  the  Mac-
ew  questionnaire  (it  is  free  to  students).  Information  about
icence  fees  is  available  at  http://www.macnew.org.
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tatistical analysis
linical,  sociodemographic  and  scale
haracteristics
atient  characteristics  are  described  using  frequencies  and
eans  ±  standard  deviations.  Analysis  of  variance  (continu-
us  variables)  and  the  Chi2 test  (categorical  variables)  were
sed  to  make  comparisons  between  the  three  cardiac  diag-
ostic  groups.  Floor  and  ceiling  effects  were  determined  at
he  lowest  (1)  and  highest  (7)  scores.
sychometric  properties
he  conceptual  model,  reliability  and  validity,  as  well  as
he  interpretability  and  the  respondent  and  administrative
urden  of  the  MacNew  questionnaire,  were  assessed  as  rec-
mmended  by  the  Scientiﬁc  Advisory  Committee  of  Medical
utcomes  Trust  [16].  Face  and  content  validities  of  the  Mac-
ew  questionnaire  have  been  established  previously  [15].
actor  analysis
n  exploratory  principal  component  factor  analysis  with
arimax  rotation  using  factor  loadings  of  ≥  0.40  was  con-
ucted  to  allocate  items  to  a  scale  in  the  French  version  of
he  MacNew  questionnaire  and  to  determine  the  degree  to
hich  this  factor  structure  replicated  the  original.
eliability
he  reliability  of  the  MacNew  questionnaire  was  evalu-
ted  by  examining  its  internal  consistency  (Cronbach’s  );
est-retest  reliability  (14-day)  was  assessed  with  intraclass
orrelation  coefﬁcient  in  a  20%  target  sample.  A  value  of
 0.70  was  considered  the  criterion  value  for  group  compar-
sons  and  ≥  0.90  for  individual  comparisons  [16].
alidity
e  hypothesized  strong  correlations  between  the  SF-36  PCS
nd  MCS  and  the  similar  MacNew  scale  constructs,  and  lower
orrelations  between  dissimilar  constructs  (r  <  0.20  =  absent;
.20—0.34  =  weak;  0.35—0.49  =  moderate;  ≥  0.50  =  strong)
s  a  test  of  construct  validity  [23].  We  tested  discrimina-
ive  validity  of  the  MacNew  questionnaire  using  the  ‘known
roup’  method  [24].  We  also  examined  the  pattern  of  Mac-
ew  scores  hypothesizing  poorer  HRQL  in  congestive  heart
ailure  patients  who  reported  perceived  health  status  on  the
ealth  transition  item  of  the  SF-36  collapsed  in  three  groups
deteriorated,  no  change,  improved)  and,  using  the  HADS
ut-off  scores  of  <  8  and  ≥  8,  in  patients  with  and  without
nxiety  or  depression  symptoms.
esults
atient characteristics
aseline  sociodemographic  and  clinical  data  were  collected
n  323  patients  with  IHD  (angina,  n  =  76;  MI,  n  =  156;  heart
ailure,  n  =  91)  who  were  recruited  at  seven  centres  in
rance  (Table  1).  The  mean  age  in  the  group  as  a  whole
as  58.6  ±  11.3  years;  patients  with  angina  (mean  age
4.2  ±  8.5  years)  were  older  than  patients  with  either  MI
r  HF  (P  <  0.001).  Patients  with  angina  were  most  likely  to
ave  high  cholesterol  (P  =  0.002);  patients  with  MI  were  most
a
≥
f
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ikely  to  be  current  smokers  (P  =  0.008)  and  to  be  physi-
ally  inactive  (P  <  0.03);  patients  with  heart  failure  were
ost  likely  to  be  hypertensive  (P  =  0.004).  There  were  more
atients  with  Canadian  Cardiovascular  Society  angina  class
I  (67.1%)  than  class  III/IV  (32.9%)  and  more  patients  with
YHA  class  II  (57.1%)  than  class  III/IV  (42.9%).
atient-centred outcome scores
acNew  questionnaire
ean  MacNew  global  scale  scores  were  4.9  ±  1.0  in  the
roup  as  a  whole  and  were  higher  in  patients  with  MI  than
n  patients  with  angina  (5.0  ±  1.0  vs.  4.6  ±  0.8,  respec-
ively;  P  <  0.05)  (Table  2).  Mean  physical  MacNew  scores
ere  4.8  ±  1.0  in  the  group  as  a  whole  and  were  higher
P  <  0.001)  in  patients  with  MI  (5.1  ±  1.0)  than  in  patients
ith  either  angina  (4.4  ±  0.09)  or  heart  failure  (4.7  ±  1.0).
here  were  no  differences  in  emotional  or  social  MacNew
cores  by  diagnosis.
hort  Form-36  Health  Survey
ean  PCS  scores  were  41.1  ±  8.0  in  the  group  as  a  whole
nd  were  higher  (P  <  0.001)  in  patients  with  MI  (43.4  ±  7.8)
han  in  patients  with  either  angina  (38.6  ±  6.6)  or  heart  fail-
re  (39.2  ±  8.2).  Although  the  MCS  scores  differed  between
he  three  diagnoses  (P  =  0.03),  no  signiﬁcant  post-hoc  differ-
nces  were  observed.
ospital  Anxiety  and  Depression  Scale
here  were  no  differences  by  diagnosis  for  either  anxiety  or
epression.
acNew item characteristics
issing  item  rates
n  the  total  group,  the  missing  MacNew  item  rate  (excluding
tem  #27,  sexual  activity)  was  always  <  2.0%  (item  24  =  1.9%);
he  missing  rates  were  <  2.7%  in  patients  with  angina,  <  1.4%
n  patients  with  MI  and  <  1.2%  in  patients  with  ischaemic
eart  failure.  Of  the  323  patients,  seven  patients  (0.02%)
issed  four  or  more  items,  with  one  patient  missing  eight
tems,  meaning  that  MacNew  global  scale  and  subscale
cores  could  be  calculated  for  each  of  the  323  patients.
loor  and  ceiling  effects
here  were  only  minimal  ﬂoor  or  ceiling  effects  for  the
ean  MacNew  physical  scale  in  the  total  group  (0.3%)  and
n  patients  with  heart  failure  (1.1%)  (Table  3).
actor analysis
ith  three  MacNew  subscales  (i.e.  physical,  emotional  and
ocial),  the  original  MacNew  factor  structure  was  conﬁrmed
or  the  French  MacNew  questionnaire,  explaining  55.9%  of
he  observed  variance  (physical  =  24.8%,  emotional  =  17.4%
nd  social  =  13.7%)  (Table  4).  Of  the  31  factor  loadings  at
 0.40  in  the  French  MacNew  questionnaire,  21  (68%)  were
ully  consistent  with  the  original  MacNew  factor  structure,
ine  (29%)  were  partially  consistent  and  only  one  (3%)  was
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Table  1  Sociodemographic  and  clinical  characteristics  of  the  total  group  of  patients  and  by  diagnosisa.
Patient  characteristics  Total  group
(n  =  323)
Angina
(n  =  76)
MI
(n  =  156)
Heart  failure
(n  =  91)
Pb
Age  (years)  58.6  ±  11.3  64.2  ±  8.5  55.9  ±  10.8  58.6  ±  12.4  <  0.001c
Sex  0.55
Male  82.7  86.8  81.4  81.3
Female  17.  13.2  18.6  18.7
Family  status  0.09
Single  9.3  6.6  7.1  15.4
Married  70.0  71.1  68.6  71.4
Other  19.8  21.1  23.1  13.2
Employment  0.26
White  collar  61.6  55.3  67.9  56.0
Blue  collar  24.1  27.6  21.2  26.4
Education  0.43
<  High  school 53.6  55.3  55.1  49.5
High  school 12.4  9.2  10.9  17.6
>  High  school 23.2  19.7  25.6  22.0
HADS  ≥  8
Anxiety  47.4  44.7  46.8  50.5  0.69
Depression  24.8  22.4  22.4  30.8  0.28
Body  mass  index  (kg/m2) 26.9  ±  4.4 26.8  ±  3.8 26.9  ±  4.3 27.1  ±  5.1 0.90
Smoker  18.6  10.5  25.0  14.3  0.008d
Hypertension  35.0  48.7  64.1  74.7  0.004c
Diabetes  14.9  18.4  11.5  17.6  0.27
Hypercholesterolaemia  51.4  67.1  49.4  41.8  0.002c
Physically  inactive  (<  3  times/week)  68.4  59.2  75.0  64.8  <  0.03e
Data are mean ± standard deviation or percentage. HADS: Hospital Anxiety and Depression Scale; MI: myocardial infarction.
a Data missing when total < 100%.
b P value by diagnosis with ANOVA for age and Chi2 for all other variables.
c Angina versus MI and heart failure.
d MI versus angina.
e MI versus angina and heart failure.
Table  2  MacNew  questionnaire,  Short  Form-36  Health  Survey  physical  and  mental  component  summaries  and  Hospital
Anxiety  and  Depression  Scale  scores  in  the  total  group  and  by  diagnosis.
Total  group  Angina  MI  Heart  failure  P
MacNew
Global  4.9  ±  1.0  4.6  ±  0.8  5.0  ±  1.0  4.8  ±  0.9  <  0.05a
Physical  4.8  ±  1.0  4.4  ±  0.9  5.1  ±  1.0  4.7  ±  1.0  <  0.001a,b
Emotional  5.0  ±  1.1  4.9  ±  1.0  5.0  ±  1.2  5.0  ±  1.1  0.67
Social  4.9  ±  1.0  4.7  ±  0.9  5.0  ±  1.1  4.8  ±  1.0  0.07
SF-36
PCS  41.1  ±  8.0  38.6  ±  6.6  43.4  ±  7.8  39.2  ±  8.2  <  0.001a,b
MCS  41.1  ±  11.0  39.7  ±  10.5  40.4  ±  11.2  43.8  ±  10.8  0.03
HADS
Anxiety  7.7  ±  4.4  7.5  ±  4.2  7.8  ±  4.6  7.6  ±  4.1  0.89
Depression  5.2  ±  3.6  4.9  ±  3.4  5.0  ±  3.7  5.9  ±  3.6  0.15
Data are mean ± standard deviation. HADS: Hospital Anxiety and Depression Scale; MCS: mental component summary; MI: myocardial
infarction; PCS: physical component summary; SF-36: Short Form-36 Health Survey.
a MI versus angina.
b MI versus heart failure.
112  B.  Pavy  et  al.
Table  3  MacNew  global  and  subscale  ﬂoor  and  ceiling  effects,  internal  consistency  (Cronbach’s  ) and  test-retest
reliability  (when  n  ≥  20)  in  the  total  group  and  by  diagnosis.
Global  Physical  Emotional  Social
Total  group
Floor  effects  (%) 0  0  0  0
Ceiling  effects  (%)  0  0.3  0  0
Cronbach’s    0.94  0.89  0.94  0.90
rtt (n  =  48)  0.73a 0.73a 0.72a 0.68a
Anginab
Floor  effects  (%)  0  0  0  0
Ceiling  effects  (%)  0  0  0  0
Cronbach’s    0.93  0.86  0.90  0.89
MI
Floor  effects  (%)  0  0  0  0
Ceiling  effects  (%)  0  0  0  0
Cronbach’s    0.95  0.89  0.94  0.90
rtt (n  =  30)  0.85a 0.79a 0.86a 0.77a
Heart  failurec
Floor  effects  (%)  0  0  0  0
Ceiling  effects  (%) 0  1.1  0  0
Cronbach’s    0.94  0.88  0.93  0.90
MI: myocardial infarction; rtt: test-retest reliability.
a P < 0.01.
b n = 11.
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ot  consistent.  Of  the  subscale  items,  three  of  the  13  phys-
cal  items  (23%),  two  of  the  14  emotional  items  (14%)  and
ve  of  the  13  social  items  (38%)  did  not  load  consistently
ith  the  original  factor  analysis.
eliability
nternal  consistency  reliability  (Cronbach’s  ) in  the  total
roup  ranged  from  0.89  to  0.94,  with  test-retest  reliabil-
ty  (intraclass  correlation  coefﬁcient)  ranging  from  0.68  to
.73  (Table  3).  In  patients  with  angina,  internal  consistency
eliability  ranged  from  0.86  to  0.93,  with  no  test-retest  reli-
bility  analysis  as  the  sample  size  was  too  small  (n  =  11);  in
atients  with  MI,  internal  consistency  reliability  ranged  from
.89  to  0.95,  with  test-retest  reliability  ranging  from  0.77
o  0.86;  in  patients  with  heart  failure,  internal  consistency
eliability  ranged  from  0.88  to  0.94,  also  with  no  test-retest
eliability  analysis  as  the  number  of  patients  was  too  small
n  =  7).
alidity
onvergent  validity
he  convergent  validity  hypotheses  for  the  MacNew  ques-
ionnaire  (i.e.  strong  correlations  [r  ≥  0.50]  between  the
acNew  physical  subscale  and  the  SF-36  PCS,  and  between
he  MacNew  emotional  subscale  and  the  SF-36  MCS)  were
onﬁrmed  in  the  total  group  and  each  diagnosis,  with  r  val-
es  ranging  from  0.51  to  0.82,  all  signiﬁcant  at  P  <  0.01
Table  5).  As  hypothesized,  the  correlations  between  the
acNew  emotional  subscale  and  the  SF-36  PCS  were  all  less
T
q
ohan  strong  and  different  in  the  total  group  and  each  diagno-
is  (P  <  0.001).  On  the  other  hand,  the  correlations  between
he  MacNew  physical  subscale  and  the  SF-36  MCS  were  strong
n  the  total  group  and  in  patients  with  either  MI  or  heart  fail-
re,  and  were  signiﬁcantly  different  only  in  patients  with  MI.
iscriminative  validity
iscriminative  validity  was  conﬁrmed  for  each  of  the
redictor  variables,  SF-36  health  transition,  anxiety  and
epression  in  the  total  group,  in  patients  with  MI  and  in
atients  with  heart  failure,  with  MacNew  score  differences
lways  signiﬁcant  at  P  <  0.001  (Table  6).  In  patients  with
ngina,  discriminative  validity  was  conﬁrmed  only  for  anxi-
ty  and  depression,  again  with  score  differences  signiﬁcant
t  P  <  0.001.  The  difference  in  the  MacNew  scores  between
atients  who  perceived  a  deterioration  in  their  health  over
he  last  year  and  those  patient  whose  health  had  either
mproved  or  was  unchanged  over  the  last  year  always  met
r  exceeded  the  MID  of  0.50  points  in  the  total  group  and
n  patients  with  MI  or  heart  failure,  but  not  in  patients  with
ngina.  More  consistently,  the  difference  in  MacNew  scores
etween  patients  with  and  without  anxiety  and  depression
lways  met  or  exceeded  the  MID  of  0.50  points  in  the  total
roup  and  in  each  diagnosis  group.
iscussionhe  psychometric  properties  of  the  French  MacNew  HRQL
uestionnaire  demonstrate  that  the  instrument  meets  rec-
mmended  reliability,  validity  and  interpretability  standards
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Table  4  Principal  component  analysis:  factor  loadings  ≥  0.40  for  each  MacNew  item  in  the  total  group.
Emotional  Physical  Social  Original  MacNew  domains
1.  Frustrated  0.77  E
2.  Worthlessa 0.68  E  S
3.  Conﬁdent  0.54  E
4.  Down  in  the  dumps  0.84  E
5.  Relaxed 0.78  E
6.  Worn  out 0.53 0.50 E P
7.  Happy  with  personal  life 0.67 E
8.  Restless  0.76  E
9.  Shortness  of  breath  0.68  P
10.  Tearful  0.68  E
11.  More  dependent  0.58  S
12.  Social  activitiesa 0.43  0.59  E  P  S
13.  Less  conﬁdence  in  youa 0.61  E  S
14.  Chest  pain  0.52  P
15.  Lack  self-conﬁdence  0.69  0.41  E  S
16.  Aching  legs  0.53  P
17.  Sports/exercise  limiteda 0.78  P  S
18.  Frightened  0.77  E
19.  Dizzy  or  lightheadedb 0.49  P
20.  Restricted  or  limiteda 0.75  P  S
21.  Unsure  about  exercisea 0.59  P  S
22.  Overprotective  family  0.63  S
23.  Burden  on  othersa 0.65  E  S
24.  Excludeda 0.68  P  S
25.  Unable  to  socialize  0.43  0.63  P  S
26.  Physically  restricteda 0.77  P  S
27.  Sexual  activity  0.52  P
Variance  explained  (%)c 24.8  17.4  13.7
Loadings < 0.40 are not displayed. E: emotional; P: physical; S: social.
a Partially conforms to the original factor analysis.
b Does not conform to the original factor analysis.
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as  a  patient-reported  outcome  measure  [17],  and  is  consis-
tent  with  the  recent  report  by  the  French  Health  Authority
for  French  cardiologists  and  researchers  [5].  An  impor-
tant  advantage  of  the  French  MacNew  questionnaire  is  that
it  has  been  validated  in  the  three  major  IHD  diagnoses
(angina,  MI  and  ischaemic  heart  failure).  When  used  to  com-
pare  HRQL  after  medical  treatment,  percutaneous  coronary
intervention  (PCI)  and  coronary  artery  bypass  graft,  the  Mac-
New  questionnaire  demonstrated  signiﬁcant  improvement
in  HRQL,  differentiating  the  patterns  of  change  between
patients  with  continued  medical  treatment,  PCI  and  coro-
nary  artery  bypass  graft  [25].  Maes  et  al.  studied  the  Dutch
version  of  MacNew  questionnaire,  showing  adequate  respon-
siveness  in  various  diagnoses  (heart  surgery,  MI  with  or
without  PCI,  stable  angina,  implantable  cardioverter  deﬁ-
brillator,  heart  failure),  with  signiﬁcant  improvement  in  the
global  scale  and  the  three  subscales  in  the  total  group  and  in
each  diagnosis  over  a  3-month  cardiac  rehabilitation  inter-
vention  [26].
The  original  MacNew  factor  structure,  with  physical,
emotional  and  social  subscales,  was  largely  conﬁrmed  with
the  French  MacNew  questionnaire,  explaining  55.9%  of
the  observed  variance  (physical  variance  explained  =  24.8%,
S
omotional  =  17.4%  and  social  =  13.7%).  Using  a  factor  load-
ng  threshold  of  >  0.40  as  in  the  original  factor  structure
nalysis,  more  than  two  thirds  of  the  items  loaded  consis-
ently  with  the  original  factor  structure  [11]. However,  38%
f  the  French  MacNew  social  subscale  items  did  not  load
onsistently  with  the  original  factor  analysis,  which  is  con-
istent  with  similar  proportions  in  the  German  [27—29]  and
ortuguese  [30],  but  not  the  Flemish  [31]  MacNew  social  sub-
cales.  The  factor  structure  of  the  MacNew  questionnaire  is
eing  further  investigated  at  this  time.  The  minimal  miss-
ng  data  rate,  never  more  than  2.7%,  means  that  MacNew
lobal  scale  and  subscale  scores  could  be  calculated  for
ach  of  the  323  patients.  In  addition,  the  absence  of  ﬂoor
ffects  and  the  very  low  ceiling  effects  on  only  the  emotional
ubscale  (0.3%  in  the  total  group  and  1.1%  in  patients  with
eart  failure)  allow  measurement  of  both  deterioration  and
mprovement  in  patient-reported  HRQL.  Further,  the  items
re  relevant,  it  is  easily  interpreted  and,  with  minimal  miss-
ng  item  responses,  overall  the  instrument  is  acceptable  to
he  patients.The  French  versions  of  the  MacNew  questionnaire,  the
F-36  and  the  HADS,  the  latter  two  questionnaires  previ-
usly  validated  in  French  [32,33],  were  completed  by  the
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Table  5  Convergent  validity  of  the  MacNew  physical  and  emotional  subscales  with  the  Short  Form-36  Heath  Survey
physical  and  mental  component  summaries  in  the  total  group  and  by  diagnosis.
Physical  subscale  Emotional  subscale  One-sided  P  value
Total  group  (n  =  323)
SF-36  PCS  0.59  0.27a <  0.001
SF-36  MCS  0.57  0.80  <  0.001
One-sided  P  value  0.34  <  0.001
Angina  (n  =  76)
SF-36  PCS  0.51  0.02a,b <  0.001
SF-36  MCS 0.46a 0.78  <  0.001
One-sided  P  value 0.33 <  0.001
MI  (n  =  156)
SF-36  PCS  0.54  0.31a <  0.01
SF-36  MCS  0.66  0.82  <  0.001
One-sided  P  value  0.05  <  0.001
Heart  failure  (n  =  91)
SF-36  PCS  0.59  0.36a <  0.05
SF-36  MCS  0.61  0.80  0.001
One-sided  P  value  0.41  <  0.001
MCS: mental component summary; MI: myocardial infarction; PCS: physical component summary; SF-36: Short Form-36 Health Survey.
a All correlations strong (r > 0.50) other than these.
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nb Not signiﬁcant; P values for all other correlations < 0.01.
atients  in  the  French  cohort  recruited  for  the  international
eartQoL  Project  [18].  As  previously  observed  in  other  lan-
uages  (e.g.  English  [14,34],  Chinese  [35],  Portuguese  [30]
nd  German  [27,29,36]),  the  French  MacNew  questionnaire
as  satisfactory  reliability  and  validity.  Internal  consistency
eliability  is  high  and  consistent  with  MacNew  reports  in
ther  languages  [26,27,29,31,34—36],  with  Cronbach’s  
 0.85  in  the  total  group  and  in  each  diagnosis.  Except  for
he  MacNew  social  subscale  in  the  total  group,  where  test-
etest  reliability  was  0.68,  the  test  reliability  exceeded  the
riterion  for  group  comparisons  (≥  0.70)  in  the  total  group
nd  in  patients  with  MI,  but  could  not  be  determined  in
atients  with  angina  or  heart  failure  due  to  small  sample
izes.
Convergent  validity  of  the  French  MacNew  questionnaire
as  conﬁrmed  with  strong  correlations,  ranging  from  0.51
o  0.82,  on  all  of  the  eight  comparisons  between  similar
acNew  and  SF-36  scales  (MacNew  physical  and  SF-36  PCS;
acNew  emotional  and  SF-36  MCS).  As  expected,  the  cor-
elations  between  the  MacNew  emotional  subscale  and  the
F-36  PCS  were  all  signiﬁcantly  lower  than  between  simi-
ar  constructs  [31,34].  However,  as  has  also  been  previously
eported  [27,30,31,34],  the  correlations  between  the  Mac-
ew  physical  subscale  and  the  SF-36  MCS  were  higher  than
xpected  in  the  total  group  as  well  as  in  patients  with  MI
nd  heart  failure.  This  may  be  a  consequence  of  the  differing
erspectives  taken  in  the  MacNew  and  SF-36  questionnaires,
articularly  in  terms  of  the  physical  items  [27,31].  The  focus
f  the  MacNew  physical  limitation  probes  is  on  how  patients
eel  and  perceive  physical  restrictions,  while  the  focus  of
he  SF-36  physical  component  probes  is  on  how  patients
ctually  perform  various  physical  tasks.  The  high  correla-
ions  between  the  MacNew  physical  subscale  and  the  SF-36
CS  may  therefore  reﬂect  a  perception  of  limitation  in  the
S
T
tacNew  questionnaire  and  a  performance  limitation  in  the
F-36  questionnaires.
Discriminative  validity  of  the  French  MacNew  question-
aire  was  partially  conﬁrmed  on  the  SF-36  health  transition
tem  in  the  total  group  and  in  patients  with  either  MI  or  with
eart  failure.  However,  by  the  SF-36  health  transition  cate-
ory  (i.e.  between  deterioration  versus  improved  and/or  no
hange  compared  with  1  year  previously),  all  the  statisti-
ally  signiﬁcant  MacNew  score  differences,  except  for  the
acNew  global  score  in  the  total  group  of  patients,  met
r  exceeded  the  MID  of  0.50  points  on  the  7-point  Mac-
ew  scale  [22]. On  the  other  hand,  discriminative  validity
as  fully  conﬁrmed  for  both  anxiety  and  depression  on  the
ADS.  Differences  in  MacNew  HRQL  scores  in  patients  with
ngina,  MI  or  heart  failure  are  related  consistently  to  the
resence  or  absence  of  anxiety  and  depression  symptoms
28,30,31,34,35,37].  Except  for  patients  with  angina,  and
hen  only  for  anxiety,  MacNew  scores  were  always  higher
n  patients  without  anxiety  or  depression  symptoms  when
ompared  with  patients  with  symptoms,  conﬁrming  previ-
us  reports  in  patients  with  angina,  MI  and  heart  failure
30,31,34,35].  The  differences  were  always  signiﬁcant  and,
xcept  for  the  difference  in  patients  with  angina  and  symp-
oms  of  anxiety,  they  always  met  or  exceeded  the  MID.
lthough  follow-up  data  were  not  possible,  given  the  cross-
ectional  design  of  the  parent  HeartQoL  Project,  a  recent
ublication  has  demonstrated  that,  in  the  6  months  follow-
ng  PCI,  MacNew  HRQL  scores  increase  signiﬁcantly  and  are
egatively  correlated  with  HADS  scores  [38].tudy limitations
here  are  several  limitations  to  the  present  validation  of
he  French  MacNew  questionnaire.  A  major  limitation  is
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Table  6  Discriminative  validity  of  MacNew  global  scale  and  subscale  scores  by  Short  Form-36  Health  Survey  health  status
transition  and  Hospital  Anxiety  and  Depression  Scale  scores  (8+)  in  the  total  group  and  by  diagnosis.
Global  Physical  Emotional  Social
Total  group  (n  =  323)
SF-36  health  transition
Improve  5.0  ±  1.0 5.0  ±  1.0 5.2  ±  1.1 5.0  ±  1.1
No  change  5.1  ±  1.0  5.1  ±  1.1  5.2  ±  1.1  5.1  ±  1.1
Deteriorate  4.6  ±  0.9  4.5  ±  0.8  4.7  ±  1.1  4.6  ±  0.9
P  value  <  0.001a,b <  0.001a,b <  0.001a,b <  0.001a,b
Anxiety
No  5.2  ±  0.8  5.0  ±  1.0  5.4  ±  0.9  5.1  ±  0.9
Yes  3.9  ±  0.7  4.2  ±  0.8  3.8  ±  0.8  4.0  ±  0.9
P  value  <  0.001  <  0.001  <  0.001  <  0.001
Depression
No  4.9  ±  0.9  4.9  ±  1.0  5.1  ±  1.0  4.9  ±  1.0
Yes  3.8  ±  0.7  4.0  ±  0.8  3.7  ±  0.9  3.9  ±  0.8
P  value  <  0.001  <  0.001  <  0.001  <  0.001
Angina  (n  =  76)
SF-36  health  transition
Improve  4.7  ±  0.9  4.5  ±  1.1  5.0  ±  1.0  4.7  ±  1.0
No  change 4.7  ±  0.9 4.3  ±  0.9  5.0  ±  1.0  4.8  ±  1.0
Deteriorate  4.6  ±  0.8  4.4  ±  0.8  4.7  ±  1.0  4.6  ±  0.9
P  value 0.699  0.761  0.460  0.892
Anxiety
No  5.0  ±  0.7 4.6  ±  0.9  5.4  ±  0.8  5.1  ±  0.8
Yes 4.2  ±  0.8 4.2  ±  0.8 4.2  ±  1.0  4.2  ±  0.8
P  value <  0.001 <  0.05 <  0.001 < 0.001
Depression
No  4.9  ±  0.7 4.6  ±  0.8 5.2  ±  0.8 4.9  ±  0.8
Yes  3.9  ±  0.9  3.9  ±  1.0  3.8  ±  1.0  3.9  ±  1.0
P  value  <  0.001  <  0.01  <  0.001  <  0.001
MI  (n  =  156)
SF-36  health  transition
Improve  5.2  ±  1.0  5.2  ±  1.1  5.2  ±  1.2  5.2  ±  1.1
No  change  5.3  ±  1.0  5.5  ±  1.0  5.3  ±  1.1  5.3  ±  1.0
Deteriorate  4.7  ±  0.9  4.7  ±  0.8  4.7  ±  1.1  4.6  ±  0.9
P  value  <  0.001a,b <  0.001a,b <  0.05b <  0.001a,b
Anxiety
No  5.5  ±  0.8  5.4  ±  0.9  5.4  ±  0.9  5.4  ±  0.9
Yes  4.4  ±  0.9  4.6  ±  1.0  4.6  ±  1.0  4.4  ±  1.0
P  value  <  0.001  <  0.001  <  0.001  <  0.001
Depression
No  5.3  ±  0.9  5.3  ±  0.9  5.3  ±  1.0  5.2  ±  1.0
Yes 3.8  ±  0.9  4.2  ±  0.7  3.8  ±  0.9  4.1  ±  0.7
P  value  <  0.001  <  0.001  <  0.001  <  0.001
Heart  failure  (n  =  91)
SF-36  health  transition
Improve  5.2  ±  0.9  5.1  ±  0.9  5.3  ±  0.9  5.1  ±  1.0
No  change  4.9  ±  1.0  4.7  ±  1.1  5.0  ±  1.1  4.9  ±  1.1
Deteriorate  4.4  ±  0.9  4.3  ±  0.9  4.6  ±  1.1  4.4  ±  0.9
P  value  <  0.01a <  0.01a <  0.05a <  0.05a
Anxiety
No  5.3  ±  0.9  5.1  ±  0.9  5.7  ±  0.9  5.2  ±  1.0
Yes  4.3  ±  0.7  4.3  ±  0.7  4.3  ±  0.8  4.3  ±  0.8
P  value  <  0.001  <  0.001  <  0.001  <  0.001
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Table  6  (Continued)
Global  Physical  Emotional  Social
Depression
No  5.1  ±  0.9  4.9  ±  1.0  5.3  ±  0.7  5.0  ±  1.0
Yes 4.2  ±  0.7 4.2  ±  0.8 4.2  ±  0.9 4.1  ±  0.7
P  value <  0.001 <  0.01 <  0.001 <  0.001
Data are mean ± standard deviation. MI: myocardial infarction; SF-36: Short Form-36 Health Survey.
a Improve versus deteriorate, P < 0.05.
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[b No change versus deteriorate, P < 0.05.
hat  prospective  data  were  not  available  from  the  cross-
ectional  study  design  of  the  HeartQoL  Project,  meaning
hat  assessment  of  responsiveness,  an  important  psychomet-
ic  property  of  patient-reported  outcome  measures,  was  not
ossible.  Maes  et  al.,  studying  the  Dutch  version  of  MacNew
uestionnaire,  showed  adequate  responsiveness  in  patients
ith  MI  with  or  without  PCI,  stable  angina,  heart  failure,
eart  surgery  or  implantable  cardioverter  deﬁbrillator,  with
igniﬁcant  improvement  in  the  global  scale  and  the  three
ubscales  in  the  total  group  and  in  each  diagnosis  over  a
-month  cardiac  rehabilitation  intervention  [26]. Another
imitation  is  that  the  data  were  collected  in  a  population
f  French-speaking  patients  with  IHD  who  attended  car-
iac  rehabilitation;  however,  this  represents  only  23%  of  the
HD  population  in  France  [39];  this  could  explain  the  rela-
ively  ‘young’  age  in  the  patients  with  heart  failure,  which  is
ot  atypical  in  heart  failure  populations  in  cardiac  rehabil-
tation.  Further  investigations  are  therefore  warranted  in
lder  French-speaking  patients  with  ischaemic  heart  fail-
re.  When  used  to  compare  change  in  HRQL,  the  MacNew
uestionnaire  demonstrated  signiﬁcant  differences  between
atients  with  continued  medical  treatment,  PCI  and  coro-
ary  artery  bypass  graft  [38,40].  The  minimal  missing  data
ate  is  a  strength  in  this  study,  meaning  that  MacNew  global
nd  subscale  scores  could  be  calculated  for  each  of  the
23  patients.  Although  there  are  no  prospective  data,  the
bsence  of  important  subscale  ﬂoor  and  ceiling  effects  is
lso  a  strength  of  the  MacNew  questionnaire,  as  it  should
ermit  measurement  of  HRQL  change,  both  deterioration
nd  improvement,  in  patient  HRQL.
onclusion
he  French  version  of  the  MacNew  HRQL  questionnaire  has
een  shown  to  be  reliable  and  valid  in  French  patients  with
he  three  major  IHD  diagnoses  (angina,  MI  and  heart  failure)
eferred  for  cardiac  rehabilitation.  The  MacNew  question-
aire  should  permit  measurement  of  disease-speciﬁc  HRQL
n  patients  undergoing  interventions  other  than  cardiac
ehabilitation;  this  needs  further  investigation,  as  does
esponsiveness  to  change,  which  was  not  possible  because  of
he  cross-sectional  design  of  the  parent  HeartQoL  Project.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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